US Stock MarketDetailed Quotes
AEMD Aethlon Medical
- 0.3846
- -0.0034-0.87%
Close Nov 1 16:00 ET
- 0.3915
- +0.0069+1.79%
Post 19:21 ET
5.36MMarket Cap-99P/E (TTM)
0.3915High0.3720Low99.90KVolume0.3859Open0.3880Pre Close37.94KTurnover0.72%Turnover RatioLossP/E (Static)13.94MShares2.349952wk High0.62P/B5.32MFloat Cap0.237552wk Low--Dividend TTM13.84MShs Float67499.9865Historical High--Div YieldTTM5.03%Amplitude0.2375Historical Low0.3790Avg Price1Lot Size
Aethlon Medical Key Stats
Quarterly+Annual
YOY
| (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 29.60%-1.75M | 3.57%-10.13M | 12.94%-2.57M | -21.87%-2.38M | 6.05%-2.7M | 9.03%-2.48M | -7.56%-10.51M | 4.92%-2.95M | 28.22%-1.95M | -53.26%-2.88M |
| Net income from continuing operations | 21.65%-2.57M | -1.48%-12.21M | 1.68%-2.43M | -21.72%-3.47M | 20.34%-3.03M | -12.94%-3.28M | -15.44%-12.03M | 34.84%-2.47M | -12.65%-2.85M | -89.62%-3.81M |
| Operating gains losses | ---- | -85.13%21.14K | --17.86K | ---- | ---- | ---- | --142.12K | --0 | --0 | ---- |
| Depreciation and amortization | -4.72%86.06K | 49.05%359.06K | 7.91%85.83K | 17.08%91.47K | 73.90%91.43K | 194.70%90.33K | 94.76%240.89K | 214.12%79.54K | 342.06%78.13K | -23.83%52.57K |
| Other non cash items | -198.30%-1.22K | -99.41%143 | -218.77%-1.22K | -104.12%-566 | -62.58%686 | -84.13%1.24K | -20.06%24.41K | -95.09%1.02K | 15.59%13.75K | 264.69%1.83K |
| Change In working capital | 30.91%599.73K | 632.58%478.66K | 53.50%-381.63K | -22.31%421.15K | -104.51%-18.98K | 697.10%458.12K | 126.02%65.34K | -299.14%-820.66K | 228.83%542.08K | 404.14%420.64K |
| -Change in receivables | ---- | --0 | --0 | --0 | ---- | ---- | 505.98%127.97K | --0 | --114.85K | --0 |
| -Change in prepaid assets | -38.62%89.87K | -102.57%-10.23K | -355.34%-292.42K | -62.86%40.78K | 27.49%95K | 47.39%146.41K | 162.54%398.17K | 141.97%114.52K | 123.74%109.79K | 4,012.58%74.52K |
| -Change in payables and accrued expense | 63.57%509.86K | 520.56%488.89K | 75.29%-89.2K | 19.82%380.37K | -149.29%-113.99K | 202.53%311.71K | -186.26%-116.25K | -163.75%-360.94K | 534.55%317.44K | 265.06%231.27K |
| -Change in other working capital | ---- | ---- | ---- | ---- | ---- | ---- | -250.00%-344.55K | -600.00%-574.25K | --0 | --114.85K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 29.60%-1.75M | 3.57%-10.13M | 12.94%-2.57M | -21.87%-2.38M | 6.05%-2.7M | 9.03%-2.48M | -7.56%-10.51M | 4.92%-2.95M | 28.22%-1.95M | -53.26%-2.88M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 73.40%-250.87K | 56.53%-4.91K | 94.19%-8.81K | 99.08%-6.77K | -459.60%-230.38K | -170.08%-943.11K | 94.68%-11.29K | -161.48%-151.49K | -1,725.68%-739.17K |
| Net PPE purchase and sale | --0 | 73.40%-250.87K | 56.53%-4.91K | 94.19%-8.81K | 99.08%-6.77K | -459.60%-230.38K | -170.08%-943.11K | 94.68%-11.29K | -161.48%-151.49K | -1,725.68%-739.17K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | 73.40%-250.87K | 56.53%-4.91K | 94.19%-8.81K | 99.08%-6.77K | -459.60%-230.38K | -170.08%-943.11K | 94.68%-11.29K | -161.48%-151.49K | -1,725.68%-739.17K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 399.12%5.38M | -85.56%1.29M | 1,715.02%42.57K | 9,501.75%177.13K | -100.12%-9.84K | 73.99%1.08M | -48.67%8.91M | 75.23%-2.64K | 86.10%-1.88K | 29,600.95%8.3M |
| Net common stock issuance | 395.74%5.38M | -85.19%1.32M | --49.76K | --186.5K | --0 | 75.34%1.09M | -48.86%8.93M | --0 | --0 | --8.31M |
| Net other financing activities | 39.35%-5.08K | -178.38%-34.78K | -172.76%-7.19K | -397.51%-9.37K | ---9.84K | ---8.37K | 85.82%-12.49K | 75.23%-2.64K | 86.10%-1.88K | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 399.12%5.38M | -85.56%1.29M | 1,715.02%42.57K | 9,501.75%177.13K | -100.12%-9.84K | 73.99%1.08M | -48.67%8.91M | 75.23%-2.64K | 86.10%-1.88K | 29,600.95%8.3M |
| Net cash flow | ||||||||||
| Beginning cash position | -62.18%5.53M | -14.80%14.62M | -54.17%8.06M | -47.88%10.26M | -13.49%12.99M | -14.80%14.62M | 73.19%17.16M | -14.13%17.59M | -15.38%19.69M | -40.48%15.01M |
| Current changes in cash | 322.12%3.63M | -258.91%-9.09M | 14.62%-2.53M | -4.99%-2.21M | -158.11%-2.72M | 23.98%-1.64M | -134.94%-2.53M | 10.88%-2.96M | 24.56%-2.1M | 340.52%4.68M |
| Effect of exchange rate changes | -593.55%-1.29K | 135.37%2.11K | 62.11%-2.26K | --5.61K | ---1.06K | ---186 | ---5.96K | ---5.96K | --0 | --0 |
| End cash Position | -29.46%9.16M | -62.18%5.53M | -62.18%5.53M | -54.17%8.06M | -47.88%10.26M | -13.49%12.99M | -14.80%14.62M | -14.80%14.62M | -14.13%17.59M | -15.38%19.69M |
| Free cash flow | 35.58%-1.75M | 9.33%-10.38M | 13.11%-2.57M | -13.51%-2.39M | 25.06%-2.71M | 2.07%-2.71M | -13.17%-11.45M | 10.67%-2.96M | 24.26%-2.1M | -88.55%-3.62M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data